Nitro–Fatty Acids Reduce Atherosclerosis in Apolipoprotein E–Deficient Mice

• Published in: Arteriosclerosis, thrombosis, and vascular biology Vol. 30; no. 5; pp. 938 - 945
• Main Authors: Rudolph, Tanja K, Rudolph, Volker, Edreira, Martin M, Cole, Marsha P, Bonacci, Gustavo, Schopfer, Francisco J, Woodcock, Steven R, Franek, Andreas, Pekarova, Michaela, Khoo, Nicholas K.H, Hasty, Alyssa H, Baldus, Stephan, Freeman, Bruce A
• Format: Journal Article
• Language: English
• Published: United States American Heart Association, Inc 01.05.2010
• Subjects: Actins - metabolism; Animals; Anti-Inflammatory Agents - administration & dosage; Anti-Inflammatory Agents - pharmacology; Antioxidants - administration & dosage; Antioxidants - pharmacology; Aortic Diseases - genetics; Aortic Diseases - metabolism; Aortic Diseases - pathology; Aortic Diseases - prevention & control; Apolipoproteins E - deficiency; Apolipoproteins E - genetics; Atherosclerosis - genetics; Atherosclerosis - metabolism; Atherosclerosis - pathology; Atherosclerosis - prevention & control; Cell Adhesion Molecules - metabolism; Cells, Cultured; Chemokine CCL2 - metabolism; Collagen - metabolism; Disease Models, Animal; Dose-Response Relationship, Drug; Foam Cells - drug effects; Foam Cells - metabolism; Injections, Subcutaneous; Lipoproteins, LDL - metabolism; Male; Mice; Mice, Knockout; Oleic Acids - administration & dosage; Oleic Acids - pharmacology; Oxidants - metabolism; Oxidative Stress - drug effects; Phosphorylation; Signal Transduction - drug effects; STAT1 Transcription Factor - metabolism
• ISSN: 1079-5642; 1524-4636
• DOI: 10.1161/ATVBAHA.109.201582

OBJECTIVE—Inflammatory processes and foam cell formation are key determinants in the initiation and progression of atherosclerosis. Electrophilic nitro–fatty acids, byproducts of nitric oxide- and nitrite-dependent redox reactions of unsaturated fatty acids, exhibit antiinflammatory signaling actions in inflammatory and vascular cell model systems. The in vivo action of nitro–fatty acids in chronic inflammatory processes such as atherosclerosis remains to be elucidated. METHODS AND RESULTS—Herein, we demonstrate that subcutaneously administered 9- and 10-nitro-octadecenoic acid (nitro-oleic acid) potently reduced atherosclerotic lesion formation in apolipoprotein E–deficient mice. Nitro–fatty acids did not modulate serum lipoprotein profiles. Immunostaining and gene expression analyses revealed that nitro-oleic acid attenuated lesion formation by suppressing tissue oxidant generation, inhibiting adhesion molecule expression, and decreasing vessel wall infiltration of inflammatory cells. In addition, nitro-oleic acid reduced foam cell formation by attenuating oxidized low-density lipoprotein–induced phosphorylation of signal transducer and activator of transcription-1, a transcription factor linked to foam cell formation in atherosclerotic plaques. Atherosclerotic lesions of nitro-oleic acid-treated animals also showed an increased content of collagen and α-smooth muscle actin, suggesting conferral of higher plaque stability. CONCLUSION—These results reveal the antiatherogenic actions of electrophilic nitro–fatty acids in a murine model of atherosclerosis.